{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:08:44Z","timestamp":1785517724302,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031624","name":"Albert Schweitzer Ziekenhuis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.breast.2026.104707","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:43:41Z","timestamp":1768895021000},"page":"104707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk factors for breast fibrosis and unfavorable cosmetic outcomes after breast conserving therapy in the contemporary treatment era: a systematic review"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-4401","authenticated-orcid":false,"given":"M.C.A.W.","family":"Notenboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Heemsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Franckena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.B.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.M.","family":"Mureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.E.","family":"Menke-Pluijmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.E.","family":"Froklage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-020-05725-z","article-title":"Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands","volume":"182","author":"Heeg","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"10.1016\/j.breast.2026.104707_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","article-title":"Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial","volume":"13","author":"Litiere","year":"2012","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.breast.2026.104707_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.breast.2026.104707_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S1470-2045(16)30067-5","article-title":"10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study","volume":"17","author":"van Maaren","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ijc.31034","article-title":"Breast conserving therapy and mastectomy revisited: breast cancer-specific survival and the influence of prognostic factors in 129,692 patients","volume":"142","author":"Lagendijk","year":"2018","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.breast.2026.104707_bib7","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1245\/s10434-016-5313-1","article-title":"Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review","volume":"23","author":"De La Cruz","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.breast.2026.104707_bib8","first-page":"2572","article-title":"Oncoplastic breast surgery: comprehensive review","volume":"21","author":"Bertozzi","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.breast.2026.104707_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/tbj.12372","article-title":"Oncoplastic surgery: pushing the limits of breast-conserving surgery","volume":"21","author":"Clough","year":"2015","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(05)01765-1","article-title":"Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques","volume":"6","author":"Anderson","year":"2005","journal-title":"Lancet Oncol"},{"issue":"5 Suppl 2","key":"10.1016\/j.breast.2026.104707_bib11","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1111\/j.1075-122X.2006.00331.x","article-title":"Oncoplastic techniques in the conservative surgical treatment of breast cancer: an overview","volume":"12","author":"Masetti","year":"2006","journal-title":"Breast J"},{"issue":"13","key":"10.1016\/j.breast.2026.104707_bib12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/bjs.11838","article-title":"Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery: a nationwide population-based study","volume":"107","author":"Heeg","year":"2020","journal-title":"Br J Surg"},{"issue":"9618","key":"10.1016\/j.breast.2026.104707_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"issue":"10237","key":"10.1016\/j.breast.2026.104707_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-Year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.breast.2026.104707_bib15","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2008.07.032","article-title":"Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC trial 22881-10882 'boost versus no boost'","volume":"44","author":"Collette","year":"2008","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2016.04.017","article-title":"Factors associated with patient-reported cosmetic outcome in the Young boost breast trial","volume":"120","author":"Brouwers","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ijrobp.2016.03.016","article-title":"Impact of sequencing radiation therapy and chemotherapy on long-term local toxicity for early breast cancer: results of a randomized study at 15-Year Follow-Up","volume":"95","author":"Pinnaro","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.breast.2026.104707_bib19","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/annonc\/mds066","article-title":"Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial","volume":"23","author":"Immink","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-8140(00)00210-3","article-title":"The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC radiotherapy and breast cancer cooperative groups","volume":"55","author":"Vrieling","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2026.104707_bib21","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.breast.2026.104707_bib23","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.breast.2026.104707_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/ijc.34057","article-title":"CANTO-RT: skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer","volume":"151","author":"Allali","year":"2022","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib25","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1016\/j.ijrobp.2012.01.050","article-title":"Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up","volume":"83","author":"Bantema-Joppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.breast.2026.104707_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.clon.2011.04.011","article-title":"The Cambridge breast intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity","volume":"23","author":"Barnett","year":"2011","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2018.06.020","article-title":"Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: results of the young boost trial","volume":"128","author":"Brouwers","year":"2018","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104707_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12032-021-01550-6","article-title":"Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?","volume":"38","author":"Colciago","year":"2021","journal-title":"Med Oncol"},{"key":"10.1016\/j.breast.2026.104707_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.breast.2016.07.013","article-title":"Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy","volume":"29","author":"De Santis","year":"2016","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jnci.2018.10.001","article-title":"Simultaneous integrated boost by intensity modulated radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - a clinical and dosimetric perspective","volume":"30","author":"Dewan","year":"2018","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2016.10.006","article-title":"Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: a multivariable prediction model","volume":"122","author":"Hammer","year":"2017","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-006-9480-9","article-title":"Predictive factors for late normal tissue complications following radiotherapy for breast cancer","volume":"106","author":"Lilla","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.clbc.2015.09.012","article-title":"Hypofractionated breast radiation: shorter scheme, lower toxicity","volume":"16","author":"Linares","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"31","key":"10.1016\/j.breast.2026.104707_bib34","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib35","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.clbc.2019.08.006","article-title":"Impact of regional nodal irradiation and hypofractionated whole-breast radiation on long-term breast retraction and poor cosmetic outcome in breast cancer survivors","volume":"20","author":"Wang","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2026.104707_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104541","article-title":"The association between breast fibrosis, cosmetic outcomes, and long-term health-related quality of life after breast-conserving therapy: a multicenter cross-sectional observational cohort study","volume":"83","author":"Notenboom","year":"2025","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ejso.2016.01.004","article-title":"Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery","volume":"42","author":"Shiina","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.breast.2026.104707_bib38","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.21037\/gs-23-371","article-title":"Expanded indications for breast-conserving surgery with oncoplastic approaches compared to conventional approaches: a single-center retrospective comparative cohort study","volume":"12","author":"Zhou","year":"2023","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12282-018-0901-5","article-title":"Fat necrosis after breast-conserving oncoplastic surgery","volume":"26","author":"Nakada","year":"2019","journal-title":"Breast Cancer"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12282-020-01046-7","article-title":"Fat necrosis in level I oncoplastic breast-conserving surgery focusing on a modified round block technique","volume":"27","author":"Zaha","year":"2020","journal-title":"Breast Cancer"},{"issue":"12","key":"10.1016\/j.breast.2026.104707_bib41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/bjs.4344","article-title":"Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised","volume":"90","author":"Cochrane","year":"2003","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.breast.2026.104707_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jso.23782","article-title":"Preoperative prediction of cosmetic results in breast conserving surgery","volume":"111","author":"Vos","year":"2015","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.breast.2026.104707_bib43","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ejso.2015.07.011","article-title":"The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy","volume":"41","author":"Lansu","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104707_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12253-011-9462-z","article-title":"Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy","volume":"18","author":"Kelemen","year":"2012","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","article-title":"Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy","volume":"82","author":"Donovan","year":"2007","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijrobp.2010.04.067","article-title":"Impact of the radiation boost on outcomes after breast-conserving surgery and radiation","volume":"81","author":"Murphy","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.breast.2026.104707_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2003.10.001","article-title":"Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer","volume":"69","author":"Hoeller","year":"2003","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104707_bib48","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: results of the prospective multicenter French trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.breast.2026.104707_bib49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/annonc\/mdv602","article-title":"Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial","volume":"27","author":"Bourgier","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104707_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1308\/rcsann.2021.0012","article-title":"A systematic review of oncoplastic volume replacement breast surgery: oncological safety and cosmetic outcome","volume":"104","author":"Rutherford","year":"2022","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"10.1016\/j.breast.2026.104707_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/SLA.0b013e3182888782","article-title":"A systematic review of oncoplastic breast-conserving surgery: current weaknesses and future prospects","volume":"257","author":"Haloua","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.breast.2026.104707_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/tbj.13193","article-title":"Oncoplastic breast surgery and radiotherapy\u2014Adverse aesthetic outcomes, proposed classification of aesthetic components, and causality attribution","volume":"25","author":"Agrawal","year":"2019","journal-title":"Breast J"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:31:41Z","timestamp":1775683901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"alternative-id":["S0960977626000172"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104707","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for breast fibrosis and unfavorable cosmetic outcomes after breast conserving therapy in the contemporary treatment era: a systematic review","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104707"}}